| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |